0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessSummary We investigated whether the occurrence of venous thrombosis in young women who use oral contraceptives might be explained by the factor V Leiden mutation, which leads to resistance to activated protein C and enhances susceptibility to thrombosis. We compared 155 consecutive premenopausal women, aged 15 to 49, who had developed deep venous thrombosis in the absence of other underlying diseases, with 169 population controls. The risk of thrombosis among users of oral contraceptives was increased 4-fold (relative risk 3·8 [95% Cl 2·4-6·0]). The risk of thrombosis among carriers of the mutation compared with non-carriers was increased 8-fold (7·9 [3·2-19·4]). Compared with women who did not use oral contraceptives and were not carriers of the mutation, the risk of thrombosis among those with both risk factors was increased more than 30-fold (34·7 [7·8-154]). Recalculation of population incidences from these relative risks shows that the absolute risk of venous thrombosis in young women who use oral contraceptives is much larger when they carry the factor V Leiden mutation. When a young woman develops thrombosis, her factor V Leiden status should be considered in counselling about her future method of contraception.
Jan P. Vandenbroucke, Ted Koster, Frits R. Rosendaal, E Briët, P.H. Reitsma, R M Bertina (1994). Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. The Lancet, 344(8935), pp. 1453-1457, DOI: 10.1016/s0140-6736(94)90286-0.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
1994
Authors
6
Datasets
0
Total Files
0
Language
English
Journal
The Lancet
DOI
10.1016/s0140-6736(94)90286-0
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access